260 related articles for article (PubMed ID: 15552597)
21. Medical therapies for melasma.
Mahajan VK; Patil A; Blicharz L; Kassir M; Konnikov N; Gold MH; Goldman MP; Galadari H; Goldust M
J Cosmet Dermatol; 2022 Sep; 21(9):3707-3728. PubMed ID: 35854432
[TBL] [Abstract][Full Text] [Related]
22. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
Torok HM
Am J Clin Dermatol; 2006; 7(4):223-30. PubMed ID: 16901182
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of retinoic acid in the treatment of melasma.
Pathak MA; Fitzpatrick TB; Kraus EW
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
Chan R; Park KC; Lee MH; Lee ES; Chang SE; Leow YH; Tay YK; Legarda-Montinola F; Tsai RY; Tsai TH; Shek S; Kerrouche N; Thomas G; Verallo-Rowell V
Br J Dermatol; 2008 Sep; 159(3):697-703. PubMed ID: 18616780
[TBL] [Abstract][Full Text] [Related]
26. Melasma Treatment: An Evidence-Based Review.
McKesey J; Tovar-Garza A; Pandya AG
Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
[TBL] [Abstract][Full Text] [Related]
27. Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
Goldman MP; Gold MH; Palm MD; Colón LE; Preston N; Johnson LA; Gottschalk RW
Dermatol Surg; 2011 Feb; 37(2):224-33. PubMed ID: 21269349
[TBL] [Abstract][Full Text] [Related]
28. Melasma in Latin America: options for therapy and treatment algorithm.
Cestari T; Arellano I; Hexsel D; Ortonne JP;
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
[TBL] [Abstract][Full Text] [Related]
29. Melasma. Etiologic and therapeutic considerations.
Grimes PE
Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140
[TBL] [Abstract][Full Text] [Related]
30. Perspectives of topical formulations for melasma.
de Freitas ACP; Rigon RB; Bagatin E; Leonardi GR
Int J Dermatol; 2023 Feb; 62(2):260-268. PubMed ID: 36083295
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels.
Garg VK; Sarkar R; Agarwal R
Dermatol Surg; 2008 Aug; 34(8):1032-9; discussion 1340. PubMed ID: 18430172
[TBL] [Abstract][Full Text] [Related]
32. A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women.
Kodali S; Guevara IL; Carrigan CR; Daulat S; Blanco G; Boker A; Hynan LS; Pandya AG
J Am Acad Dermatol; 2010 Dec; 63(6):1030-5. PubMed ID: 20889235
[TBL] [Abstract][Full Text] [Related]
33. Different therapeutic modalities for treatment of melasma.
Azzam OA; Leheta TM; Nagui NA; Shaarawy E; Hay RM; Hilal RF
J Cosmet Dermatol; 2009 Dec; 8(4):275-81. PubMed ID: 19958431
[TBL] [Abstract][Full Text] [Related]
34. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of a broad-spectrum sunscreen in the treatment of melasma.
Vázquez M; Sánchez JL
Cutis; 1983 Jul; 32(1):92, 95-6. PubMed ID: 6349944
[TBL] [Abstract][Full Text] [Related]
37. A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Bhawan J; Grimes P; Pandya AG; Keady M; Byers HR; Guevara IL; Colón LE; Johnson LA; Gottschalk R
Am J Dermatopathol; 2009 Dec; 31(8):794-8. PubMed ID: 19755910
[TBL] [Abstract][Full Text] [Related]
38. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK
J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma.
Kumari R; Thappa DM
Indian J Dermatol Venereol Leprol; 2010; 76(4):447. PubMed ID: 20657143
[TBL] [Abstract][Full Text] [Related]
40. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
Figueiredo Souza L; Trancoso Souza S
Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
